These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16961753)

  • 1. Can differences in breast cancer utilities explain disparities in breast cancer care?
    Schleinitz MD; DePalo D; Blume J; Stein M
    J Gen Intern Med; 2006 Dec; 21(12):1253-60. PubMed ID: 16961753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer.
    Wheeler SB; Carpenter WR; Peppercorn J; Schenck AP; Weinberger M; Biddle AK
    Breast Cancer Res Treat; 2012 Jan; 131(1):207-16. PubMed ID: 21842244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis.
    Sher DJ; Wittenberg E; Taghian AG; Bellon JR; Punglia RS
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):469-76. PubMed ID: 17967514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.
    McQuellon RP; Muss HB; Hoffman SL; Russell G; Craven B; Yellen SB
    J Clin Oncol; 1995 Apr; 13(4):858-68. PubMed ID: 7707112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
    Freedman RA; Virgo KS; He Y; Pavluck AL; Winer EP; Ward EM; Keating NL
    Cancer; 2011 Jan; 117(1):180-9. PubMed ID: 20939011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
    Keating NL; Kouri E; He Y; Weeks JC; Winer EP
    Med Care; 2009 Jul; 47(7):765-73. PubMed ID: 19536008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preference weights for chemotherapy side effects from the perspective of women with breast cancer.
    Kuchuk I; Bouganim N; Beusterien K; Grinspan J; Vandermeer L; Gertler S; Dent SF; Song X; Segal R; Mazzarello S; Crawley F; Dranitsaris G; Clemons M
    Breast Cancer Res Treat; 2013 Nov; 142(1):101-7. PubMed ID: 24129976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes.
    Hassett MJ; Li H; Burstein HJ; Punglia RS
    Breast Cancer Res Treat; 2020 May; 181(1):43-51. PubMed ID: 32185586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy.
    Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL
    Breast J; 2012; 18(3):203-13. PubMed ID: 22487337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.
    Sail K; Franzini L; Lairson D; Du X
    Ethn Health; 2012; 17(3):309-23. PubMed ID: 22066691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.
    Roberts MC; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes KE; Carey LA; Troester MA; Wheeler SB
    J Clin Oncol; 2016 Jan; 34(2):130-8. PubMed ID: 26598755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
    McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
    Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.
    Hershman DL; Tsui J; Wright JD; Coromilas EJ; Tsai WY; Neugut AI
    J Clin Oncol; 2015 Mar; 33(9):1053-9. PubMed ID: 25691670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.
    Sher DJ; Wittenberg E; Suh WW; Taghian AG; Punglia RS
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):440-6. PubMed ID: 18963542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
    Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D
    JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.